Cytokine response gene #6 (CR6), cloned from interleukin 2-stimulated T lymphocytes, is homologous to GADD45 and MyD118, genes which promote cell cycle arrest and apoptosis. To determine how this gene family could possibly mediate both cell survival/proliferation and cell cycle arrest/death, transfectants were generated so that the genes could be expressed ectopically, independently from their normal inducing agents. In cycling retinoblastoma protein-negative (pRb-) cells, ectopic CR6 expression blocked G2/M transition, but did not prevent G1/S transition so that endoreduplication resulted. By comparison, when CR6, GADD45, and MyD118 genes were expressed ectopically in proliferating pRb + cells, either G1/S or G2/M transition was eectively blocked, so that there was no endoreduplication. Consistent with these ®ndings, in proliferating pRbcells, ectopic expression of CR6 promoted the expression of both G1 and G2/M cyclins. By comparison, in pRb + cells, the expression of G1 cyclins was increased, while expression of the mitotic cyclins was decreased. However, in pRb + cells, cyclin-dependent kinase activities associated with both G1 and G2/M cyclins were decreased. Moreover, ectopic expression of all three genes resulted in the expression of the CKI, p21, both in pRb 7 and pRb + cells. The physiologic induction of CR6 expression by IL2 in quiescent normal human T cells occurs transiently in the ®rst half of G1, coordinately with the expression of p21. Therefore, this gene family regulates G1 and G2, and promotes either cell growth or arrest by a common mechanism.
Introduction
The maintenance of normal cellular integrity requires that the cell decipher signals that indicate whether to progress in the cell cycle, to revert to quiescence, to begin terminal dierentiation, to arrest temporarily to allow for DNA repair, or to undergo apoptosis. It has been assumed that separate and distinct mechanisms are responsible for each of these seemingly disparate cellular responses. Therefore, the discovery of a new gene family comprised of three very similar gene products associated with distinct cellular responses was perplexing.
The ®rst member of this new gene family to be described was termed Growth Arrest and DNA Damage gene #45 (GADD45), because it was discovered after ultraviolet (UV) light-mediated DNA damage of Chinese hamster ovary cells (Fornace et al., 1998) . Studies characterizing this gene revealed that it encodes a small (*18 kD), very acidic (pI=4.2) protein that localizes to the nucleus. In addition to UV irradiation other DNA damaging agents also found to induce GADD45 expression include g irradiation and alkylating agents, such as methyl methanesulfonate (Hollander et al., 1993) .
Consistent with its proposed role in growth arrest after DNA damage, GADD45 mRNA expression has been found to be induced by p53 (Kastan et al., 1992; Zhan et al., 1994a) . Also, it binds to Proliferating Cell Nuclear Antigen (PCNA), but this property has yet to be translated into the proposed growth arrest function of GADD45 Smith et al., 1994) . Gadd45 has also been found to bind to the CyclinDependent Kinase (CDK) Inhibitor (CKI), p21 WAF1/Cip1 Vairapandi et al., 1996) . However, exactly how this property is involved in the putative function of Gadd45 as a growth arrest protein remains obscure, in that despite binding to p21, there are no data indicating that Gadd45 actually facilitates p21-induced growth arrest.
The second member of this gene family to be described, Myeloid Dierentiation gene #118 (MyD118), was isolated from myeloid leukemia cells induced by the cytokine interleukin 6 (IL6) to undergo terminal growth arrest and dierentiation to macrophages (Abdollahi et al., 1991) . Subsequent studies revealed that MyD118 is also a primary response gene induced by Tumor Growth Factor b (TGFb), which causes the same myeloid leukemia cells to undergo rapid apoptosis (Selvakumaran et al., 1994) . Therefore, in contrast to temporary growth arrest associated with GADD45 expression after DNA damage, MyD118 expression is associated with permanent growth arrest, and as well, apoptosis, depending upon which cytokine is the stimulus (Vairapandi et al., 1996) .
The MyD118 encoded protein is remarkably similar to the protein encoded by GADD45, in that it is also *18 kD, and it shares 57% amino acids with Gadd45 (Abdollahi et al., 1991) . Also like Gadd45, the MyD118 gene product is very acidic (pI=4), localizes to the nucleus, and has been reported to bind to both PCNA and p21 (Vairapandi et al., 1996) . However, in contrast to GADD45, MyD118 expression is not regulated by p53. Ectopic expression of GADD45 and MyD118 in several human tumor cell lines was found to reduce colony yields (Smith et al., 1994; Zhan et al., 1994b) . In addition, GADD45 and MyD118 synergize with each other, and with p21 in the suppression of NIH3T3 colony formation. Therefore, although these genes are induced by dierent stimuli and apparently by dierent transcription factors, both appear to function as negative regulators of cell growth.
Even so, the molecular mechanism(s) responsible for the decrease in colony formation has remained obscure, despite a decade of investigation. For example, it is still confusing as to whether these gene products promote growth arrest, apoptosis, or both. Also, it is not clear as to whether the cellular phenotype that results from the expression of these genes is a direct or an indirect eect. Given the enigma surrounding the role of these genes in cellular physiology, it was quite curious to discover that the third member of this new gene family is one of a number of genes induced by the lymphocyte growth factor, IL2.
IL2, the ®rst of the interleukins to be puri®ed to homogeneity (Smith et al., 1983) and to be cloned (Taniguchi et al., 1983) , is now well characterized as a growth-promoting and survival factor for all three of the major subsets of lymphocytes, including T cells, B cells and Natural Killer (NK) cells (Smith, 1988) . The IL2-T cell system has served as a unique model for studies of cell cycle regulation, in that peripheral blood T cells are physiologically in a state of Go. Activation via the T cell antigen receptor (TCR) signals G0 to G1 transition or cell cycle`competence', but the cells remain as small, metabolically quiescent lymphocytes until activation via the IL2 receptor (IL2R) promotes progression' through the G1 phase of the cell cycle and transition to the S phase (Cantrell and Smith, 1984) . There is a critical threshold of IL2/IL2R interactions that must be surpassed before the cells will progress beyond the G1 restriction point (R point). Accordingly, the IL2R somehow counts the number of interactions with IL2, and signals in a quantal, all-ornone fashion when the cell can make the irrevocable step to begin DNA synthesis (Smith, 1995) .
To begin to understand the molecular events triggered by IL2Rs, we developed a new technique to identify and isolate immediate/early genes expressed after cytokine stimulation of T cells, termed Sulfhydryl Labeling and Anity Puri®cation (SLAP) (Beadling et al., 1993) . Thus far, eight novel genes have been identi®ed as Cytokine Response (CR) genes, and one, CR6, was found to encode a *18 kD protein that is homologous to Gadd45 and Myd118 (Beadling et al., 1993) . Recently, a protein identical to Cr6 was also identi®ed using a yeast two-hybrid method, which revealed that when expressed ectopically, it binds to and activates a Mitogen Activated Protein Kinase Kinase Kinase (MAPKKK), termed MTK1 (Takekawa and Saito, 1998) .
Human Cr6 shares 55% overall amino acid identity with both human Gadd45 and Myd118 (Takekawa and Saito, 1998) . Even more noteworthy, human and murine Cr6 have been highly conserved, with 97% amino acid homology (unpublished). Also, like the other two members of this new gene family, Cr6 is highly acidic, with a pI=4.
Since IL2 is well known to promote lymphocyte survival and cell cycle progression, the discovery that an IL2-induced gene is homologous to two other genes already established as growth inhibitors was a paradox.
However, it is impossible to divorce the eects of these proteins from other upstream and downstream events triggered simultaneously by the various inducing agents utilized. Therefore, to circumvent these problems, we sought to express CR6 and the other members of the family independently of any other signal. Accordingly, stable transfectants were created, which express CR6 and the other two members of this gene family, either constitutively, or under hormonal control.
Our results, detailed in this report, indicate that CR6, GADD45 and MyD118, all produce either G1 or G2 arrest when expressed ectopically in cycling cells. The molecular mechanism responsible for this eect is attributable to their induction of p21 expression. Accordingly, it appears that cells employ a common mechanism to regulate growth, dierentiation, and DNA repair.
Results

CR6 Expression blocks G2/M transition and causes endoreduplication of HeLa cells
To examine the eect of CR6 expression on cell growth independently of IL2 stimulation, we attempted to establish stable cell lines expressing CR6 using HeLa cells. HeLa cells do not express functional pRb or p53, the two major cell cycle checkpoint proteins (Levine, 1997; Niculescu et al., 1998) . Therefore, we hoped that it would be easier to derive stable transfectants expressing CR6 in these cells, especially if CR6 promoted cell cycle arrest like GADD45 and MyD118. The ORF of CR6 was tagged with a hemagglutinin (HA) epitope, and cloned into an expression plasmid. Two weeks after transfection and drug selection, it was evident that there were fewer colonies obtained in HA-CR6 transfected cells than obtained with the control plasmids (data not shown).
Even so, there were clearly drug-resistant clones. Figure 1a shows Western blots using anti-HA to probe total cell lysates from ®ve clones transfected with the HA-CR6 plasmid and the control vector, as well as the parental HeLa cells. Clone CR6.4 had undetectable HA-CR6, while clones CR6.12, CR6.14, and CR6.15 were all positive to varying degrees. The results of experiments to be shown subsequently are only from clone CR6.12, although similar results were also obtained with all of the clones, and the magnitude of the eects observed were proportional to the amount of Cr6 expressed by each clone.
CR6-stably transfected HeLa cells grew fairly normally in culture medium containing 10% FCS, with only a slight decrease in the percentage of cells in G1, and a slight increase in the percentage of cells in S, G2 and M, as shown by quantitative DNA analysis using propidium iodide (PI) and¯ow cytometry ( Figure 1b , left panels).
Given these ®ndings, next serum was withdrawn to test whether removal of its growth promoting and survival eects would reveal more dramatically any growth arrest eect of CR6 expression. After 5 days without serum, the PI pro®les of the parental HeLa cells and the vector-transfected HeLa cells revealed no dierence from the PI pro®les in the presence of serum (Figure 1b, right panels) . By comparison, HA-CR6-stably transfected HeLa cells had a much lower percentage of cells in G1, a higher percentage of cells in G2/M, and many cells had a DNA content that was greater than 4 N. Notably, the percentage of S phase cells in clone HA-CR6.12 was approximately the same as that observed in the controls, suggesting that there was an inecient G1 blockade. Moreover, there was a second S phase population, between 4 N and 8 N.
The higher than normal DNA content was not attributable to multinuclear cells, a possible explanation that was excluded by direct observation under microscopy, or to cell clumps, which was excluded bȳ ow cytometry pro®les. Instead, the accumulation of a distinct peak at a DNA content of 8 N suggested that discrete rounds of DNA replication were responsible, indicating that cells underwent endoreduplication, i.e. DNA was re-synthesized without mitosis. By comparison, there was not a detectable increase of cells with 52 N DNA content, thereby excluding apoptosis during this culture interval without serum.
Eect of CR6 on HeLa cell cyclin expression
Because CR6-stably transfected HeLa cells were blocked at the G2/M transition but underwent endoreduplication, cyclin levels were examined in these cells. Flow cytometry was used to analyse cyclin expression, because this technique makes it possible to correlate cyclin expression in individual cells with their DNA content, and their actual position in the cell cycle (Darzynkiewicz et al., 1994 (Darzynkiewicz et al., , 1996 . Data for cyclin E expression in cells grown in 10% FCS, and after withdrawal from serum for 5 days are shown in Figure 2a , with DNA content shown on the X axis derived from PI, and cyclin expression on the Y axis. In the presence of serum ( Figure 2a , left panels), parental HeLa cells and vector-transfected HeLa cells both had similar levels of cyclin E vs DNA content, with increasing amounts in G1 phase (2 N DNA), and decreasing levels as S phase progressed. These ®ndings are consistent with the role of cyclin E in signaling the onset of G1/S phase transition. By comparison, clone HA-CR6.12 had even higher levels of cyclin E in G1.
When serum was withdrawn for 5 days, as shown in the right panels of Figure 2a , there were slightly lower levels of cyclin E in G1 cells in the parental HeLa cells, and in the vector controls, consistent with the lack of serum-derived growth factors. In contrast, there was an elevation of cyclin E in both G1 and G2/M phase cells in the HA-CR6.12 cells. Moreover, there was also readily detectable cyclin E in the S phase cells, both between 2 N and 4 N, and between 4 N and 8 N ( Cyclin B, which accumulates in the G2 phase and signals the onset of mitosis, was found to be expressed normally in the cell populations cultured in 10% FCS ( Figure 2c , left panels). However, after serum withdrawal (Figure 2c , right panels), the eect of HA-CR6.12 expression was readily discernible, with high levels of cyclin B, and an accentuation of the number of cells expressing cyclin B and containing 8 N DNA.
Overall, there were elevated levels of all three cyclins monitored in the cells expressing HA-CR6, even when the growth-promoting eect contributed by serum was withdrawn.
CR6 expression blocks either G1/S or G2/M transition in U2OS cells
To express CR6 in cells that contain functional pRb and p53, an inducible expression vector was chosen, in that it was anticipated that it would be dicult to create stable transfectants that expressed CR6 constitutively. Therefore, U2OS, an osteogenic sarcoma cell line that has functional pRb and p53, was cotransfected with two plasmids, one containing the Retinoid6Receptor (R6R), and another containing HA-CR6 under the control of the R6R response element. HA-CR6 expression was induced by adding the synthetic steroid Ponasterone A to the cell culture, which binds to the R6R and transciptionally activates genes under its control. Several positive clones were isolated, and clones that expressed HA-GADD45 and HA-MyD118 were also isolated. Some neomycin resistant clones did not express HA-CR6, and their phenotype was the same as that of parental U2OS cells. Therefore, these clones were used as Neo R control cells. The induction of HA-CR6, HA-GADD45 and HA-MyD118 protein expression after 48 h of Ponasterone A exposure as detected by Western blot is shown in Figure 3a .
Ponasterone A induced the cells to became larger, which was evident as measured by¯ow cytometry as shown in Figure 3b . Similar results were obtained with U2OS cells induced to express HA-GADD45 and HAMyD118 (Figure 3b , lower panels). The forward scatter channel, which measures the cell size is shifted to the right in all three cells induced by Ponasterone A. These cell size changes were not observed in U2OS cells induced to express other CR genes, e.g. CR8 (data not shown).
To determine the eect of CR6 expression on the cell cycle, HA-CR6 was induced by Ponasterone A for 2 days, and the cells were then examined by¯ow cytometry. For the Neo R control cells ( Figure 3c , upper panels), there was almost no change in the proportion of cells in G1, S and G2/M phases upon exposure to Ponasterone A. By comparison, induction of clone HA-CR6.5 clearly resulted in either a G1 or a G2 arrest. Thus, the percentage of G1 cells increased from 44 ± 76%, S phase decreased from 22 to 3%, and G2/M phase cells decreased from 35 to 21%, but did not disappear entirely, thereby indicating an eective G2/M block. Expression of HA-GADD45 also decreased the percentage of S phase from 26 to 11%, while G1 increased from 51 ± 67%, and G2/M phase cells remained at 22%. Similar, but less marked results were obtained using HA-MyD118 transfected cells (Figure 3c , lower panels) Also, there was no endoreduplication detectable by¯ow cytometry in U2OS cells induced to express HA-CR6, HA-GADD45, or HA-MyD118. Also, there were no cells with 52 N DNA content, indicative that apoptosis had not occurred appreciably within 48 h of Ponasterone A induction.
Eect of CR6 on U2OS cyclin expression
To analyse the eect of CR6 expression on the cell cycle further, cyclin levels were monitored. As shown in Figure 4a , by Western blot analysis, the cyclin D1 level was increased somewhat after 48 h of Ponasterone A induction. By comparison, cyclin E levels in Ponasterone A induced clone HA-CR6.5 were indistinguishable from that in uninduced cells, and as well, indistinguishable from the cyclin E levels in both uninduced and induced Neo R cells. However, both cyclin A and cyclin B levels in Ponasterone A induced clone HA-CR6.5 cells were diminished compared with the uninduced cells or with the Neo R cells. Examination of the cyclin levels using¯ow cytometry provided more information than was obtained by Western blot analysis. Thus, as shown in Figure 4b , it is readily apparent that the Ponasterone A-induced expression (48 h) of clone HA-CR 6.5 resulted in the accumulation of high cyclin E levels in both G1 phase and G2 phase cells. As a consequence of the ecient G1 arrest, there were very low numbers of S phase cells, so that there was only a minor contribution to the total amount of cyclin E by this subset. These data are consistent with the apparent unchanged cyclin E levels in whole cell lysates as monitored by Western blot analysis (Figure 4a ), but more revealing, in that cyclin E levels are actually increased in both G1 phase and G2/M phase cells. However, the decreased number of S phase cells compensated for these increases. Similar results were obtained with the HA-GADD45 and HA-MyD118 transfectants (data not shown). Experiments to monitor the time course of changes in cyclin E levels upon Ponasterone induction of CR6 revealed a discernible arrest of cells in G1 as early as 12 h after induction, and an increase in the level of cyclin E in both G1 and G2. By 36 h after addition of Ponasterone A, the G1 and G2/M cyclin E levels had become maximal, and the proportion of S phase cells that express cyclin E were at a minimum. Cyclin D levels were also monitored by¯ow cytometry, and were slightly increased in U2OS cells induced to express CR6 (data not shown).
Cyclin A levels monitored by¯ow cytometry are shown in Figure 4c . After 48 h induction with Ponasterone A, cyclin A levels were decreased in S phase and G2/M phase cells (Figure 4c , lower right panel) compared with uninduced HA-CR6.5 cells Figure 3 Ponasterone A induced U2OS cell expression of CR6, GADD45 and MyD118. Equal numbers of cells were plated at a low density and incubated for 2 days with or without 2.5 mM Ponasterone A. Cell lysates were prepared for Western blot analysis, or cells were ®xed for¯ow cytometry analysis. Accordingly, in U2OS cells, where CR6 expression caused an ecient G1 blockade, there were decreased levels of the mitotic cyclins, in contrast to the eect of CR6 expression in HeLa cells where there was an inecient G1 block, and elevated mitotic cyclins. However, in both instances, there was an ecient G2 blockade.
Eect of CR6 expression on CDK activity
In view of the Cr6-induced G1 and G2 block of U2OS cells, it was of interest to determine the CDK activities in the Ponasterone A-induced cells. Therefore, the same lysates used for the Western blot analysis ( Figure 4a ) were examined after immunoprecipitation with Cdk4 speci®c antibody for cyclin D/Cdk4 kinase activity using GST-pRb as substrate, or immuno-precipitation with cyclin E, A, B speci®c antibodies for kinase activity using Histone H1 as substrate. Compared with uninduced cells, Ponasterone A induction of CR6 expression for 48 h resulted in a slightly decreased cyclin D1/cdk4 kinase activity, but even more readily detectable decreases in CDK activities associated with cyclins E, A, and B (Figure 5a ). In view of the increased levels of cyclin E proteins (Figure 4a ), the decreased levels of cyclin E/CDK2 kinase activities are particularly noteworthy. Although there was a marked decrease in cyclin B1 levels, the decrease in cyclin B1 kinase activity was not as great as the decline in cyclin A kinase activity.
CR6 expression stimulates p21 expression
Because the induction of CR6 expression in U2OS cells resulted in either G1 or G2 arrest, with decreased CDK activities associated with cyclins D, E, A and B, the status of pRb phosphorylation was examined. As shown in Figure 5b by Western blot analysis, in Ponasterone A-induced clone HA-CR6.5 cells, pRb was hypophosphorylated after 48 h, compared with uninduced clone HA-CR6.5 cells, and with both uninduced as well as induced Neo R control cells. Given the low cyclin-CDK activities observed after induction of CR6 expression, the CDK inhibitors p21 and p27 were examined next. As shown in Figure 5b , Ponasterone A induction of CR6 expression resulted in a readily detectable expression of p21, but no change in p27 levels. As well, there was no change in the levels of Cdk2 and Cdc2.
Since p53 activates p21 gene transcription, p53 protein levels were determined after 48 h of Ponaster- As is readily apparent, p53 expression was actually decreased, rather than increased, compared with the controls. Given these ®ndings, it was of interest to determine whether the expression of Cr6 by HeLa cells also resulted in the induction of p21 expression. As shown in Figure 6a , the HeLa clones constitutively expressing Cr6 clearly contained much greater amounts of p21 than did either the parental cells or the vector controls. Finally, lysates from U2OS cells induced to express GADD45 and MyD118 were compared with cells induced to express CR6 (Figure 6b ). There was an induction of p21 in each of the cell lines, with the magnitude of p21 induction re¯ective of the level growth arrest detected in each cell population ( Figure  3c ).
IL2 induces p21 expression in synchronized IL2R+ human T cells
Previous studies, which demonstrated an IL2-induced decrease of the p27 during G1, revealed that simultaneously, there was an IL2-induced increase in p21 expression (Nourse et al., 1994) . Therefore, in view of these results and our own data with HeLa and U2OS cells, the expression of p21 and CR6 in IL2-stimulated T cells was monitored using Northern blot analysis. To determine the time course of CR6 and p21 expression after IL-2 stimulation, IL2R+ human T Figure 5 Eect of CR6 expression on cyclin kinase activity and cell cycle regulators in U2OS cells. (a) After 2 days with or without Ponasterone A induction, cell lysates were immunoprecipitated with the indicated antibodies, and immune complexes were assayed for kinase activity using as substrates GST-pRb (for Cdk4) or Histone H1 (for cyclin E, A and B1). CR6 regulates G1 and G2 W Fan et al lymphocytes were induced by IL2 to undergo a semisynchronous G1 progression into S phase, which begins at *12 h, and peak levels of DNA synthesis are detectable at 24 ± 36 h (Cantrell and Smith, 1984) . As shown in Figure 6c , CR6 mRNA was readily detectable within 30 min of IL2 stimulation, with peak levels observed at 2 h. Thereafter, CR6 mRNA declined progressively to low levels by 36 h. p21 mRNA expression is also clearly induced by IL2, with readily detectable increases by 30 min, and peak levels observed at 1 ± 2 h. A densitometric scan of CR6 and p21 mRNA expression from this blot is shown in Figure 6d , revealing the coordinate IL2-induced expression of CR6 and p21 mRNA.
Discussion
The results from these studies indicate that CR6 is a member of a novel family of three cellular regulatory genes that increase the expression of the CKI, p21 when expressed ectopically. Since all three genes induce growth arrest when expressed ectopically, it was odd to discover that one of them, CR6, is an immediate/early gene induced by the prototypical lymphocyte growth factor, IL2, which is so well characterized as a cell cycle`progression factor' (Cantrell and Smith, 1984; Smith, 1988) .
In search of a plausible explanation for these ®ndings, it is pertinent that ectopic expression of p21 itself produces a cellular phenotype indistinguishable from that produced by the ectopic expression of CR6. Thus, as recently reported by Niculescu et al. (1998) , expression of p21 in a variety of cell lines revealed that in addition to its recognized role in blocking G1/S transition, p21 also contributes to the inhibition of G2/M transition. Just as we observed with ectopic CR6 expression, the ectopic expression of p21 in cycling tumor cell lines led to dierent responses, dependent upon whether the cells expressed functional pRb. Cycling pRb-positive cells arrested predominantly in G1 upon p21 expression, with a small, but persistent subpopulation of cells arrested in G2. By comparison, pRb-negative cells arrested primarily in G2, with a lesser proportion in G1.
Our experiments also showed that DNA endoreduplication occurred in pRb-negative HeLa cells, further supporting the conclusion discussed by Niculescu et al. (1998) , that pRb functions normally to determine the R point, thereby preventing DNA replication. When cells lack pRb, p21 expression cannot prevent DNA replication, but G2/M transition is still inhibited, so that mitosis is prevented and 44 N DNA content results. Of interest was the observation that the negative eect of CR6 expression in HeLa cells did not become obvious until the cells were placed in serum-free medium. Apparently, the growthpromoting factors in serum induce the expression of positive activities that overcome the negative eect of CR6, so that mitosis can still take place. By comparison, induction of CR6 expression in U2OS cells, which contain functional pRb, eectively blocked both DNA synthesis and mitosis, even in the presence of serum. Therefore, the cells were arrested in either G1 or G2, so that there could be no endoreduplication.
It is also relevant that our results are identical to those obtained by Medema et al. (1998) , who used a tetracycline-repressible system to regulate p21 expression in U2OS cells. These investigators also found a marked suppression of cyclin E/CDK2 kinase activity, and an ecient blockade in either G1 or G2. In our experiments, CR6 expression in U2OS cells resulted in decreased expression of the S phase and G2/M phase cyclins, and also markedly decreased cyclin A and cyclin B/CDK kinase activity. These results are consistent with the CR6-induced expression of p21, the resultant decreased cyclin-associated kinase activities, and the persistence of hypophosphorylated pRb. Since the expression of both cyclin A and cyclin B are under the transcriptional control of E2F (Schulze et al., 1995) , prevention of pRb phosphorylation by CR6-induced p21 eectively blocks the E2F transcriptional activation of cyclin A and then cyclin B expression. In addition, there is also an inhibition of kinase activity, which eectively blocks any cells that were already in G2 at the time of CR6-induced p21 expression.
The molecular mechanism responsible for the CR6-induced expression of p21 is obscure. Initially, it seemed likely that CR6 might function like the p14 Alternative Reading Frame (ARF) of p16, and stimulate p21 expression via p53, by preventing its degradation through Mdm2 (Kamijo et al., 1998; Pomerantz et al., 1998; Sherr, 1998; Zhang et al., 1998) . However, p53 levels were actually decreased in CR6 expressing cells rather than increased, and moreover, Mdm2 was undetectable (data not shown). Furthermore, CR6 also increased p21 levels in HeLa cells, in which p53 is inactivated by E6. Therefore, the CR6-induced expression of p21 appears to occur via a p53-independent pathway.
Our ®ndings illustrate that even though CR6 is normally expressed transiently, only in the ®rst half of G1 in synchronized resting cells, it can also eectively arrest proliferating cells in G2 when expressed ectopically. However, this function remains cryptic, as long as the ordered sequence of the cell cycle is followed. Thus, the function of CR6 in the normal cell cycle can be likened to the function of p25 Rum1 in the yeast cell cycle, which is also expressed transiently in G1 (Benito et al., 1998; Moreno and Nurse, 1994) . Although these two genes have no primary sequence homology, they appear to play a similar role, coordinating the dierent phases of the cell cycle. p25 Rum1 is an inhibitor of both the G1 and G2 cyclin/ CDK complexes, and it has been proposed that a transient inhibition of these complexes by p25 Rum1 in G1 is important in determining the time required to achieve the minimum cell size required to pass START (Benito et al., 1998) . Also during G1, by inhibiting G2 cyclin/CDK complexes, p25 Rum1 prevents the onset of mitosis in cells that have not yet initiated DNA replication (Benito et al., 1998; Correa-Bordes et al., 1997; Correa-Bordes and Nurse, 1995) .
Accordingly, it appears that during the initiation of normal cell cycle progression in G1, mammalian cells also employ mechanisms to inhibit the activity of both the G1 and G2 cyclin/CDK complexes. Thus, in quiescent normal cells, the CR6-dependent induction of the transient expression of p21 by mitogenic growth factors like IL2 promotes and regulates the duration of G1 progression. Simultaneously, by inhibiting the CR6 regulates G1 and G2 W Fan et al mitotic cyclin/CDK complexes during G1, CR6-induced p21 expression prevents premature entry into M, thereby coordinating G1 and G2. By comparison, in cycling cell lines, when GADD45 is expressed after DNA damage, or when MyD118 is expressed in response to IL6, p21 expression is also induced, causing the cells to arrest in either G1 or G2, thereby allowing for DNA repair or dierentiation to occur.
Materials and methods
Cell cultures
T cells were isolated from peripheral blood of healthy donors by Ficoll-hypaque (Pharmacia) density centrifugation, and cultured at 10 6 cells/ml in RPMI 1640 (GIBCO) supplemented with 10% FCS (Gemini Bioproducts) and antibiotics. T cells were initially activated with OKT3 (Ortho pharmaceuticals) at 1 : 10 000 dilution for 3 days. then washed and cultured for 11 days in the presence of 500 pM recombinant human IL2 (Takeda Chemicals). Cells were subsequently washed and replaced in culture for 36 h in medium without IL2, after which 50 ng/ml phorbol dibutyrate (PdBu) was added to increase high-anity IL2R expression. After 12 h, cells were washed free of PdBu and replaced into fresh culture medium for 12 h prior to IL2 restimulation. This treatment yielded a synchronized IL2R+ T cell population which was arrested in early G1, and comprised of 490% CD8+ T cells. HeLa and U2OS cells were grown in DMEM with 10% FCS.
RNA extraction and Northern blots
IL2R+T cells were treated with IL2 as described in ®gure legends. Total RNA was isolated by RNAzol TM B (Tel-TEst, Inc. Friendswood, TX, USA) and 20 mg of total RNA was run on 1.2% formaldedyde-agarose gels, and then transferred to Hybond-N + membranes (Amersham). Membranes were hybridized with random-primed 32 P-labeled DNA probes (41610 6 c.p.m./ml) at 658C overnight in Rapid-Hyb solution (Amersham). 32 P-labeled bands were detected by autoradiography.
Constructs and transfections
The human CR6 cDNA containing the full-length coding region of CR6 was isolated by PCR, cloned into pCDNA3HA (modi®ed from Invitrogen pCDNA3). HeLa cells were transfected by pCDNA3HACR6 using the calcium phosphate transfection method. The stable clones were selected by using 1 mg/ml G418 (Sigma). The positive clones were identi®ed by Western blot analysis. The ecdysone inducible system (Invitrogen) is used in U2OS cells. The regulator vector pVgRXR constitutively expressing two subunits of a functional ecdysone receptor from Drosophila was cotransfected with the second inducible expression vector pIND, which has the ecdysone-responsive promoter. In the presence of the inducer hormone (Ponasterone A), the functional ecdysone receptor binds upstream of the ecdysone responsive promoter and activates expression of the inserted gene. pINDHACR6 was constructed by inserting the HACR6 fragment cut from pCDNA3HACR6. The human pINDHAGADD45 construct was made by inserting a PCR fragment of the full-length coding region of GADD45. The mouse pINDHAMyD118 construct was made by inserting a PCR fragment of the coding region (1 ± 141 Amino Acids) of MyD118. The pVgRxR and pIND plasmids (ratio 1 : 9) were co-transfected into U2OS cells by the calcium phosphate method. Stable cells were selected by Zosin (0.6 mg/ml, Invitrogen) and G418 (0.6 mg/ml, Sigma). The positive inducible clones were identi®ed by Western blot analysis.
Serum withdrawal from HeLa cells and induction of CR6 in U2OS cells by Ponasterone A
Equal numbers of HeLa, Vector control HeLa, and CR6.12 HeLa cells were plated in DMEM with 10% FCS. After an overnight culture, cells were washed with PBS X3 and starved for serum in DMEM with 0% FCS for 5 days, then collected by trypsinization, washed with PBS, and ®nally ®xed in cold 70% Ethanol for further FACS analysis. For U2OS cells, an equal number of cells growing exponentially were seeded, then 2.5 mM of Ponasterone A (Invitrogen) dissolved in Ethanol (®nal concentration of Ethanol in the culture is 0.1%) was added to the cell culture. After 24 h, 2.5 mM of Ponasterone A was re-added because of its consumption. After induction, cells were trypsinized, washed with PBS, and either ®xed in cold 70% ethanol for FACS analysis, or lysates were prepared for immunoblot analysis and kinase assays.
Antibodies, immunoblot and in vitro kinase assays
Mouse MoAbs reactive with human cyclin A (BF683) and human cyclin B (GNS-1) (PharMingen) were used for Western blot and immunoprecipiation. A mouse MoAb to human cyclin E (HE12) was used for Western blot analysis, and clone (HE67) was used for immunopreicipation. Mouse MoAbs reactive with human pRb (G3-245, PharMingen), human p21 (Ab-1) (Oncogene), and sheep anti-human p53 (Ab-7) (Oncogene) were used for Western blot analysis. Rabbit polyclonal anti human p27 (Transduction Laboratories), cdk2 (sc-163) and cdc2 (sc-954) (Santa Cruz) were used for Western blot analysis. After the treatment, cells were lysed in NP-40 buer (0.5% NP-40, 50 mM Tris, pH 7.4, 150 mM NaCl, 50 mM NaF, 1 mM Na3VO4, 1 mM PMSF) containing a protease inhibitor cocktail tablet (Boehringer Mannheim). The lysates were cleared by centrifugation, and protein concentrations were determined by Bradford assay (Bio-Rad). For immunoblot analysis, lysates were resolved on SDS ± PAGE and transferred to PVDF membrane (NEN Dupont). The ECL blotting system (NEN Dupont or Amersham) was used according to the instructions of the manufacturer. For kinase assays, lysates were ®rst immunoprecipitated for 4 h to overnight at 48C with antibody and protein A-Sepharose beads (Boehringer Mannheim). Beads were washed twice with NP-40 lysis buer, and twice with kinase assay buer (50 mM Tris pH 7.4, 0.1 mM EDTA, 0.1 mg/ml BSA, 0.1% 2-ME, 150 mM NaCl, 10 mM MgCl2 and 1 mM DTT). For the kinase assay reaction, beads were suspend in 29 ml kinase buer, 2 ml Histone H1 (1 mg/ml, Boehringer Mannheim) or 2 ml of GST-Rb (Santa Cruz), 3 ml 1 mM ATP, 1 ml [r-32 P]ATP (NEN Dupont, 6000 Ci/mmol) After incubation for 30 min. at 308C with occasional mixing, the samples were boiled in SDS ± PAGE loading buer and separated by electrophoresis. Phosphorylated proteins were visualized by autoradiography.
Flow cytometry analysis for DNA content and cyclins
After treatment, cells were collected and washed with PBS and ®xed in cold 70% ethanol at 720C for overnight. For DNA content, cells were stained with Propidium iodide (50 mg/ml) plus RNAase (5 mg/ml) in PBS. For cyclin staining the manufacturer's instructions described in detail (Darzynkiewicz et al., 1994; were followed (Pharmingen). Antibodies used for staining were mouse MoAb reactive with human cyclin E, A or B1 (clones: HE12 for cyclin E, BF683 for cyclin A, GNS-1 for cyclin B. PharMingen) and the secondary antibody used for staining was FITC-goat anti mouse antibody (Jackson's Lab). The¯uorescence of cells stained with cyclin MoAb and PI was measured using a FACSCalibur¯ow cytometer (Becton Dickinson). The data from 1.5610 4 cells per sample were collected, stored and analysed using Cellquest software (Becton Dickinson).
